- Home
- VKTX vs PFSI Comparison
VKTX vs PFSI Comparison
Compare VKTX & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- PFSI
- Stock Information
- Founded
- VKTX 2012
- PFSI 2008
- Country
- VKTX United States
- PFSI United States
- Employees
- VKTX N/A
- PFSI N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- PFSI Finance: Consumer Services
- Sector
- VKTX Health Care
- PFSI Finance
- Exchange
- VKTX Nasdaq
- PFSI Nasdaq
- Market Cap
- VKTX 4.7B
- PFSI 5.4B
- IPO Year
- VKTX 2015
- PFSI 2013
- Fundamental
- Price
- VKTX $32.87
- PFSI $108.91
- Analyst Decision
- VKTX Strong Buy
- PFSI Buy
- Analyst Count
- VKTX 12
- PFSI 5
- Target Price
- VKTX $106.75
- PFSI $124.60
- AVG Volume (30 Days)
- VKTX 3.5M
- PFSI 280.7K
- Earning Date
- VKTX 02-05-2025
- PFSI 01-30-2025
- Dividend Yield
- VKTX N/A
- PFSI 1.11%
- EPS Growth
- VKTX N/A
- PFSI N/A
- EPS
- VKTX N/A
- PFSI 3.20
- Revenue
- VKTX N/A
- PFSI $2,777,781,000.00
- Revenue This Year
- VKTX N/A
- PFSI N/A
- Revenue Next Year
- VKTX N/A
- PFSI $38.21
- P/E Ratio
- VKTX N/A
- PFSI $33.68
- Revenue Growth
- VKTX N/A
- PFSI 83.37
- 52 Week Low
- VKTX $20.92
- PFSI $83.03
- 52 Week High
- VKTX $99.41
- PFSI $119.13
- Technical
- Relative Strength Index (RSI)
- VKTX 26.61
- PFSI 65.14
- Support Level
- VKTX $32.51
- PFSI $95.30
- Resistance Level
- VKTX $43.55
- PFSI $101.07
- Average True Range (ATR)
- VKTX 2.15
- PFSI 2.23
- MACD
- VKTX -0.41
- PFSI 1.11
- Stochastic Oscillator
- VKTX 17.78
- PFSI 97.91
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a United States-based financial services company primarily engaged in mortgage lending. The company operates through three segments: production, servicing, and investment management. The company's production and servicing segment together form the mortgage banking business that includes mortgage loan origination, acquisition, and sale activities; while the investment management segment includes investment manager's activities, such as performing diligence, and managing acquired assets. The company generates the majority of revenue from its mortgage banking business.